As the level of tumor markers and gene mutations of KRAS/NRAS/PIK3CA/BRAF are detected, it can be found that the concentrations of CEA, CA24-2, and CA19-9 of patients with CRC are quite higher. The gene discussed is NRAS; the disease is colorectal carcinoma.